INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

97 hedge funds and large institutions have $42.5M invested in Inozyme Pharma in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 20 closing their positions.

Holders
97
Holders Change
-8
Holders Change %
-7.62%
% of All Funds
1.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
30
Reduced
28
Closed
20
Calls
$13K
Puts
$1K
Net Calls
+$12K
Net Calls Change
+$20K

Top Buyers

1
PFCS
1
Pale Fire Capital SE
Czech Republic
$401K
2
Aberdeen Group
2
Aberdeen Group
United Kingdom
$297K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$514K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.51M
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$100K

Top Sellers

1
EAM
1
Eventide Asset Management
Massachusetts
$0
2
SVCM
2
Saturn V Capital Management
Texas
$454K
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$1.07M
4
Millennium Management
4
Millennium Management
New York
$1.13M
5
Wellington Management Group
5
Wellington Management Group
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
OMC
26
Overbrook Management Corp
New York
$200K – – –
Citadel Advisors
27
Citadel Advisors
Florida
$164K -$398K -436,894 -71%
NL
28
Nuveen LLC
North Carolina
$146K +$146K +160,879 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$142K – – –
Morgan Stanley
30
Morgan Stanley
New York
$124K -$10K -11,006 -7%
Charles Schwab
31
Charles Schwab
California
$111K -$19K -20,868 -15%
XT
32
XTX Topco
Cayman Islands
$101K +$71.8K +78,948 +249%
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$100K +$100K +110,376 New
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$97.3K +$41.7K +45,824 +75%
BCM
35
Bridgeway Capital Management
Texas
$96.3K +$26.9K +29,600 +39%
Raymond James Financial
36
Raymond James Financial
Florida
$89K +$21.5K +23,666 +32%
GCP
37
GSA Capital Partners
United Kingdom
$82K +$82K +89,651 New
Two Sigma Advisers
38
Two Sigma Advisers
New York
$80.4K +$8.83K +9,700 +12%
Two Sigma Investments
39
Two Sigma Investments
New York
$80.2K +$51.1K +56,169 +176%
ACM
40
ADAR1 Capital Management
Texas
$79.9K +$10.5K +11,500 +15%
OIA
41
OneDigital Investment Advisors
Kansas
$73.7K +$27.3K +30,000 +59%
Qube Research & Technologies (QRT)
42
Qube Research & Technologies (QRT)
United Kingdom
$72.8K +$72.8K +80,006 New
AQR Capital Management
43
AQR Capital Management
Connecticut
$72K +$72K +79,077 New
Walleye Capital
44
Walleye Capital
New York
$67.7K -$149K -163,245 -69%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$65.9K -$4.36K -4,792 -6%
Bank of America
46
Bank of America
North Carolina
$65.8K -$29.1K -32,003 -31%
Barclays
47
Barclays
United Kingdom
$56K -$26.4K -29,331 -32%
D.E. Shaw & Co
48
D.E. Shaw & Co
New York
$48.6K +$32.4K +35,568 +200%
UBS Group
49
UBS Group
Switzerland
$48.2K +$15.3K +16,803 +46%
4WM
50
49 Wealth Management
Texas
$38.1K +$38.1K +41,850 New
1
2
3 4 5